| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Departments of Clinical Pharmacology [M. M., B. J., H. G. E., B. B-D.], Internal Medicine I, Division of Oncology [R. M. M., B. S., G. G. S.], Surgery [M. G., R. J.], and Diagnostic Radiology [T. H.], Vienna University School of Medicine, A-1090 Vienna, Austria
Several anticancer drugs fail to exhibit sufficient activity against solid tumors in vivo despite effective inhibition of tumor cell growth in vitro. This may be due to impaired drug transfer from plasma into solid tumors. The present study, therefore, aimed at measuring interstitial tumor 5-fluorouracil (5-FU) pharmacokinetics and 5-FU transfer rates from plasma into the tumor interstitium in breast cancer patients.
Microdialysis probes were inserted into the primary tumor and the periumbilical s.c. adipose layer of 10 breast cancer patients (8 females and 2 males) scheduled to receive neoadjuvant chemotherapy due to locally advanced breast cancer. Thereafter, patients received 5-FU (600 mg/m2, i.v.). 5-FU kinetics were followed in plasma and tumor and s.c. interstitial fluid.
Mean interstitial 5-FU load, expressed as area under curve (AUC), in breast tumors was 61 ± 11% (means ± SE) of the mean plasma 5-FU load. 5-FU displayed similar kinetics in the interstitial space of s.c. adipose tissue and tumor tissue. A high interstitial tumor AUC was associated with increased tumor response. There was no association with tumor response for s.c. or plasma AUC of 5-FU.
Measurement of interstitial drug concentrations in breast tumors by in vivo microdialysis may predict response to chemotherapy. This information may explain drug resistance in some patients and help to optimize dosing and administration schedules. In the future, selection of novel cytotoxic compounds with favorable tumor penetration characteristics may become possible.
1 To whom requests for reprints should be addressed, at Department of Clinical Pharmacology, AKH, Währinger Gürtel 18–20, A-1090 Vienna, Austria. Phone: 43-1-40400-2981; Fax: 43-1-40400-2998; E-mail: Klin-Pharmakologie@univie.ac.at.
Received 3/27/97. Accepted 5/14/97.
This article has been cited by other articles:
|
|
 |
|
  W. C. Zamboni, S. Strychor, E. Joseph, D. R. Walsh, B. A. Zamboni, R. A. Parise, M. E. Tonda, N. Y. Yu, C. Engbers, and J. L. Eiseman Plasma, Tumor, and Tissue Disposition of STEALTH Liposomal CKD-602 (S-CKD602) and Nonliposomal CKD-602 in Mice Bearing A375 Human Melanoma Xenografts Clin. Cancer Res., December 1, 2007; 13(23): 7217 - 7223. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Muller, A. dela Pena, and H. Derendorf Issues in Pharmacokinetics and Pharmacodynamics of Anti-Infective Agents: Distribution in Tissue Antimicrob. Agents Chemother., May 1, 2004; 48(5): 1441 - 1453. [Full Text] [PDF]
|
|
|
|
 |
|
 R. K. Benjamin, F. H. Hochberg, E. Fox, P. M. Bungay, W. F. Elmquist, C. F. Stewart, J. M. Gallo, J. M. Collins, R. P. Pelletier, J. F. de Groot, et al. Review of microdialysis in brain tumors, from concept to application: First Annual Carolyn Frye-Halloran Symposium Neuro-oncol, January 1, 2004; 6(1): 65 - 74. [Abstract] [PDF]
|
|
|
|
|
|
W. C. Zamboni, A. C. Gervais, M. J. Egorin, J. H. M. Schellens, D. R. Hamburger, B. J. Delauter, A. Grim, E. G. Zuhowski, E. Joseph, D. Pluim, et al. Inter- and Intratumoral Disposition of Platinum in Solid Tumors after Administration of Cisplatin Clin. Cancer Res., September 1, 2002; 8(9): 2992 - 2999. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Muller Science, medicine, and the future: Microdialysis BMJ, March 9, 2002; 324(7337): 588 - 591. [Full Text] [PDF]
|
|
|
|
 |
|
 S. N. Ettinger, C. C. Poellmann, N. A. Wisniewski, A. A. Gaskin, J. S. Shoemaker, J. M. Poulson, M. W. Dewhirst, and B. Klitzman Urea as a Recovery Marker for Quantitative Assessment of Tumor Interstitial Solutes with Microdialysis Cancer Res., November 1, 2001; 61(21): 7964 - 7970. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Pietras, A. Östman, M. Sjöquist, E. Buchdunger, R. K. Reed, C.-H. Heldin, and K. Rubin Inhibition of Platelet-derived Growth Factor Receptors Reduces Interstitial Hypertension and Increases Transcapillary Transport in Tumors Cancer Res., April 1, 2001; 61(7): 2929 - 2934. [Abstract] [Full Text]
|
|
|
|
|
|
M. Brunner, U. Hollenstein, S. Delacher, D. Jäger, R. Schmid, E. Lackner, A. Georgopoulos, H. G. Eichler, and M. Müller Distribution and Antimicrobial Activity of Ciprofloxacin in Human Soft Tissues Antimicrob. Agents Chemother., May 1, 1999; 43(5): 1307 - 1309. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
